Posted On: 06/28/2016 6:05:13 PM
Post# of 72446
Depends on whom you ask over there lol. Dr. Reddy's thinks the drug might also work for elapsing-remitting multiple sclerosis, but no trial has been done on that. In contrast, Prurisol might also work for eczema.
"Dr. Reddy's is a willing buyer and in a position to develop XP23829. The company is planning to integrate the drug, an oral tablet, into its existing internal development efforts, which have been focused heavily on mild-to-moderate psoriasis. Although XenoPort recently announced mixed phase 2 results, Dr. Reddy's sees real potential not only for psoriasis, but also for relapsing-remitting multiple sclerosis (RRMS)."
http://www.biopharmadive.com/news/xenoport-se...ys/416542/
"Dr. Reddy's is a willing buyer and in a position to develop XP23829. The company is planning to integrate the drug, an oral tablet, into its existing internal development efforts, which have been focused heavily on mild-to-moderate psoriasis. Although XenoPort recently announced mixed phase 2 results, Dr. Reddy's sees real potential not only for psoriasis, but also for relapsing-remitting multiple sclerosis (RRMS)."
http://www.biopharmadive.com/news/xenoport-se...ys/416542/
Quote:
A failed drug gets $490 million? Hey, wasn't Prurisol a failure?
(0)
(0)
